We undertook a secondary analysis of the Australasian Collaborative Trial of Repeat Doses of Corticosteroids (ACTORDS) Mid-childhood Outcome Study data to determine whether the effect of repeat betamethasone on cardiometabolic function differed in those born with and without FGR. Children in New Zealand were assessed at 6-8 years by DEXA, intravenous glucose tolerance test (Minimal Model), ambulatory blood pressure and spirometry. FGR was defined as severe FGR at trial entry or customised birthweight <3 rd centile.
Results: Of 266 children with ≥1 test of cardiometabolic function, FGR occurred in 43/127 (34%) children exposed to repeat betamethasone, and 44/139 (32%) exposed to placebo. There was a significant interaction between FGR and the effect of repeat betamethasone on height (height z-score mean difference [95% CI] FGR 0.59 [0.01, 1.17], non-FGR -0.29 [-0.69, 0 .10], p=0.01 for interaction). FGR did not influence the effect of repeat betamethasone on cardiometabolic function, which was similar between treatment groups (Table 1) .
Conclusions: In mid-childhood, repeat antenatal betamethasone had a positive effect on height and no adverse effect on cardiometabolic function among children with FGR. FGR is not a contraindication to use of repeat antenatal corticosteroid treatment. Methods: Newborn piglets were instrumented for hemodynamic monitoring and administration of fluids and medications. Piglets were subjected to 1 hour of hypoxia followed by reoxygenation with 21-25% oxygen and observed for 4 days. An iv bolus of DOX (30 mg/kg) or normal saline (control) was given at 5 minutes of reoxygenation in a blinded, block-randomized fashion (n=8/group). Sham-operated piglets (n=6) received no HR. Renal injury was investigated by measuring plasma creatinine, urinary N-acetyl-D-glucosaminidase (NAG) levels and renal tissue lactate. Both renal MMP-2 and 9 activities were also studied by gelatin zymography.
POST-RESUSCITATION DOXYCYCLINE ALLEVIATES
Results: Both HR groups received similar hypoxia with severe lactate acidosis (pH~7.08; lactate 13 mmol/L). There were no differences in heart rate, systemic arterial pressure, and neurologic scoring between HR groups over 4 days of recovery. DOX-treated piglets had higher urine output than those of controls over 4 days. Renal MMP-2 activity, urine NAG/Cr ratio and plasma creatinine of the DOX group were significantly lower than those of the control group, and there were all negatively correlated with total urine output. The renal tissue MMP-9 and lactate were not different between HR groups.
Conclusions: In newborn piglets surviving HR, postresuscitation administration of DOX may attenuate renal injury through MMP inhibition. (-0.65, 0.25) 
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